Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrid Gouma

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Infection Control and Hospital Epidemiology|December 2, 2021
Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children's hospital during coronavirus disease 2019 (COVID-19) pandemicBrian T Fisher, Anna Sharova, Craig L K Boge, et al.
Journal of the Pediatric Infectious Diseases Society|December 2, 2020
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationRishi R Goel, Sokratis A Apostolidis, Mark M Painter, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.
Cell|February 24, 2022
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
SARS-CoV-2 Seroprevalence Among Parturient WomenDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Science Immunology|July 31, 2020
SARS-CoV-2 seroprevalence among parturient women in PhiladelphiaDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Emerging Infectious Diseases|July 1, 2021
Predictors of Nonseroconversion after SARS-CoV-2 InfectionWeimin Liu, Ronnie M Russell, Frederic Bibollet-Ruche, et al.
Immunity|August 28, 2021
Rapid induction of antigen-specific CD4<sup>+</sup> T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccinationMark M Painter, Divij Mathew, Rishi R Goel, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Infection Control and Hospital Epidemiology|December 2, 2021
Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children's hospital during coronavirus disease 2019 (COVID-19) pandemicBrian T Fisher, Anna Sharova, Craig L K Boge, et al.
Journal of the Pediatric Infectious Diseases Society|December 2, 2020
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationRishi R Goel, Sokratis A Apostolidis, Mark M Painter, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19Elizabeth M Anderson, Caroline Diorio, Eileen C Goodwin, et al.
Cell|February 24, 2022
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
SARS-CoV-2 Seroprevalence Among Parturient WomenDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Science Immunology|July 31, 2020
SARS-CoV-2 seroprevalence among parturient women in PhiladelphiaDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Emerging Infectious Diseases|July 1, 2021
Predictors of Nonseroconversion after SARS-CoV-2 InfectionWeimin Liu, Ronnie M Russell, Frederic Bibollet-Ruche, et al.
Immunity|August 28, 2021
Rapid induction of antigen-specific CD4<sup>+</sup> T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccinationMark M Painter, Divij Mathew, Rishi R Goel, et al.
Pageof 7